Join
Live feed
·
INSIDERFilingvia Quantisnow
Inovio Pharmaceuticals Inc. logo

CFO Kies Peter converted options into 9,007 shares and covered exercise/tax liability with 5,322 shares, increasing direct ownership by 15% to 28,052 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INO (Inovio Pharmaceuticals Inc.) and more on Quantisnow.